DK153542C - Analogifremgangsmaade til fremstilling af ornithin- eller argininsalte af forgrenede alfa-keto-syrer - Google Patents

Analogifremgangsmaade til fremstilling af ornithin- eller argininsalte af forgrenede alfa-keto-syrer

Info

Publication number
DK153542C
DK153542C DK110879A DK110879A DK153542C DK 153542 C DK153542 C DK 153542C DK 110879 A DK110879 A DK 110879A DK 110879 A DK110879 A DK 110879A DK 153542 C DK153542 C DK 153542C
Authority
DK
Denmark
Prior art keywords
arginal
ornithin
alfa
analogy
branched
Prior art date
Application number
DK110879A
Other languages
Danish (da)
English (en)
Other versions
DK153542B (da
DK110879A (da
Inventor
Mackenzie Walser
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Publication of DK110879A publication Critical patent/DK110879A/da
Publication of DK153542B publication Critical patent/DK153542B/da
Application granted granted Critical
Publication of DK153542C publication Critical patent/DK153542C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK110879A 1978-03-17 1979-03-16 Analogifremgangsmaade til fremstilling af ornithin- eller argininsalte af forgrenede alfa-keto-syrer DK153542C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/887,570 US4228099A (en) 1978-03-17 1978-03-17 Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
US88757078 1978-03-17

Publications (3)

Publication Number Publication Date
DK110879A DK110879A (da) 1979-09-18
DK153542B DK153542B (da) 1988-07-25
DK153542C true DK153542C (da) 1988-12-05

Family

ID=25391422

Family Applications (1)

Application Number Title Priority Date Filing Date
DK110879A DK153542C (da) 1978-03-17 1979-03-16 Analogifremgangsmaade til fremstilling af ornithin- eller argininsalte af forgrenede alfa-keto-syrer

Country Status (17)

Country Link
US (1) US4228099A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5838421B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU517505B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE874900A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1115729A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2910221A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK153542C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES478710A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI72118C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2419723A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2017094B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE48336B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1202904B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU81057A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7902136A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO151119C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE446724B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296127A (en) * 1979-04-18 1981-10-20 The Johns Hopkins University Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof
DE3438455A1 (de) * 1984-10-19 1986-06-26 Institut Dr. Ziegler, Bettingen L-lysin- und l-histidinpyruvat
US4677121A (en) * 1985-01-22 1987-06-30 The Johns Hopkins University Method of inhibiting muscle protein degradation
US4752619A (en) * 1985-12-23 1988-06-21 The Johns Hopkins University Nutritional supplement for treatment of uremia
US4744990A (en) * 1986-09-25 1988-05-17 W. R. Grace & Co. Hydantoins as animal food supplements
US4871552A (en) * 1986-09-25 1989-10-03 W. R. Grace & Co.-Conn. Hydantoins as animal food supplements
US5639731A (en) * 1987-05-22 1997-06-17 Pripps Bryggerier Ab Amino acids for the preparation of a beverage
FR2615734B1 (fr) * 1987-05-27 1989-12-01 Synthelabo Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
AT393079B (de) * 1989-03-06 1991-08-12 Lubec Gert Pharmazeutische verwendung von agmatin
AT393080B (de) * 1988-11-25 1991-08-12 Lubec Gert Pharmazeutische verwendung von arginin (salzen)
SE462463B (sv) * 1988-12-02 1990-07-02 Decken Alexandra V D Livs- och fodermedel innehaallande ketosyror
JP2522034B2 (ja) * 1988-12-27 1996-08-07 味の素株式会社 α−ケト酸・アミノ酸塩化合物及びその製造方法
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
WO1996010927A1 (fr) 1994-10-07 1996-04-18 Firmenich S.A. Compositions aromatisantes et procede d'aromatisation
US5591736A (en) * 1995-07-03 1997-01-07 The Johns Hopkins University Method of retarding the progression of chronic renal failure
EP1377339A4 (en) * 2001-04-04 2006-05-31 Critical Therapeutics Inc PROCEDURE FOR PREVENTING AKUTER NIERENINSUFFIZIENZ
JP4778913B2 (ja) * 2004-11-15 2011-09-21 協和発酵バイオ株式会社 Ｌ−オルニチン結晶およびその製造方法
MX2007006171A (es) * 2004-11-26 2007-10-08 Ucl Business Plc Composiciones que comprenden ornitina y acetato.
GB0426141D0 (en) * 2004-11-26 2004-12-29 Ucl Biomedica Plc Treatment
PT3686183T (pt) 2009-04-03 2022-10-03 Ocera Therapeutics Inc Fenilacetato de l-ornitina e métodos de preparação do mesmo
CN102625699B (zh) 2009-06-08 2014-08-20 Ucl商业有限公司 使用l-鸟氨酸苯乙酸盐治疗门静脉高压和恢复肝功能
AU2011312042B2 (en) 2010-10-06 2015-08-20 Ocera Therapeutics, Inc. Methods of making L-ornithine phenyl acetate
CN107206021B (zh) 2014-11-24 2021-09-03 Ucl商业有限公司 使用降氨疗法治疗与肝星状细胞激活相关的疾病
AU2016308641B2 (en) 2015-08-18 2022-02-03 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
CN106674057A (zh) * 2015-11-09 2017-05-17 江西乐维生物药业有限公司 L-精氨酸a-酮基异己酸盐的制备方法
US11219611B2 (en) 2015-11-13 2022-01-11 Ocera Therapeutics, Inc. Formulations of L-ornithine phenylacetate
WO2017090007A1 (en) * 2015-11-29 2017-06-01 Rao M Surya Compositions and methods for the treatment of urea cycle disorders and hepatic diseases
US11066352B2 (en) 2017-05-11 2021-07-20 Ocera Therapeutics, Inc. Processes of making L-ornithine phenylacetate
EP3716966A4 (en) 2017-11-29 2021-08-18 Hull, Edgar, L., Jr. ALPHA-KETOACID COMPOSITIONS FOR THE TREATMENT OF HYPOALBUMINEMIA
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
US12109254B2 (en) 2017-11-29 2024-10-08 Edgar Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA814483A (en) * 1969-06-03 Abe Kyuji L-ornithine-l-aspartate
GB1034358A (en) 1963-05-01 1966-06-29 Chugai Pharmaceutical Co Ltd Body-protein-biosynthesis promoting composition
FR1432756A (fr) 1965-02-11 1966-03-25 D Opochimiotherapie Lab Pyruvates d'amino-acides et leur procédé de préparation
US3441650A (en) * 1965-07-23 1969-04-29 Lab Jacques Logeais Sa Therapy of ammonical intoxications by di-l-ornithine alpha-ketoglutarate
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
US4100293A (en) * 1974-04-15 1978-07-11 The Johns Hopkins University Treatment of hepatic disorders with therapeutic compositions comprising keto analogs of essential amino acids
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same

Also Published As

Publication number Publication date
SE446724B (sv) 1986-10-06
AU517505B2 (en) 1981-08-06
ES478710A1 (es) 1980-01-16
JPS5838421B2 (ja) 1983-08-23
FR2419723A1 (fr) 1979-10-12
LU81057A1 (fr) 1979-09-07
CA1115729A (en) 1982-01-05
IE790993L (en) 1979-09-17
DK153542B (da) 1988-07-25
US4228099A (en) 1980-10-14
IE48336B1 (en) 1984-12-12
NO151119B (no) 1984-11-05
DK110879A (da) 1979-09-18
GB2017094A (en) 1979-10-03
FI72118B (fi) 1986-12-31
SE7902401L (sv) 1979-10-16
IT1202904B (it) 1989-02-15
FR2419723B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-10-29
BE874900A (fr) 1979-07-16
IT7921071A0 (it) 1979-03-16
DE2910221A1 (de) 1979-09-20
GB2017094B (en) 1982-07-07
AU4515479A (en) 1979-09-20
NO790903L (no) 1979-09-18
DE2910221C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-04-28
FI790901A7 (fi) 1979-09-18
NL7902136A (nl) 1979-09-19
JPS54163518A (en) 1979-12-26
FI72118C (fi) 1987-04-13
NO151119C (no) 1985-02-13

Similar Documents

Publication Publication Date Title
DK153542C (da) Analogifremgangsmaade til fremstilling af ornithin- eller argininsalte af forgrenede alfa-keto-syrer
DK158788C (da) Analogifremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK158225C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK153540C (da) Analogifremgangsmaade til fremstilling af platin-diamin-komplekser
DK156779A (da) Fremgangsmaade til fremstilling af cycloalkyltriazoler
DK129879A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK303079A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK149773C (da) Analogifremgangsmaade til fremstilling af 3-quinolincarboxylsyrederivater
DK186179A (da) Fremgangsmaade til fremstilling af carbapenemderivater
DK163580C (da) Analogifremgangsmaade til fremstilling af cyclohexancarboxylsyrederivater
DK123679A (da) Fremgangsmaade til fremstilling af carboxylpersyrer
DK20279A (da) Fremgangsmaade til fremstilling af 4-pyridon-3-carboxylsyrederivater
DK324979A (da) Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf
DK331679A (da) Fremgangsmaade til fremstilling af phenylalkansyrederivater
DK257779A (da) Fremgangsmaade til fremstilling af chlor-styryl-cyclopropan-carboxylsyrederivater
DK215079A (da) Fremgangsmaade til fremstilling af phenylaminothiothiopheneddikesyrer
DK73379A (da) Fremgangsmaade til fremstilling af halogensubstituerede mercaptoacylaminsyrer
DK150471C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK160485C (da) Fremgangsmaade til fremstilling af arylglyoxylsyrer
DK508881A (da) Fremgangsmaade til fremstilling af oploesninger af 7-amincophelosporansyrer
DK186279A (da) Fremgangsmaade til fremstilling af alkylcarbapenemderivater
DK233379A (da) Fremgangsmaade til fremstilling af arylglyoxylsyrer
DK156399C (da) Analogifremgangsmaade til fremstilling af spiro-quinolylhydantoin-derivater
DK431479A (da) Fremgagnsmaade til fremstilling af 3-exomethylencepham-sulfoxider
DK145179A (da) Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol

Legal Events

Date Code Title Description
PUP Patent expired